Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome
Open Access
- 1 January 2011
- journal article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 10 (1) , 7
Abstract
Glycemic control and management of dyslipidemia to reduce cardiovascular risk are major therapeutic goals in individuals with type 2 diabetes mellitus (T2DM). This study was performed to evaluate the effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ (PPARα/γ) agonist, on both lipid and glycemic parameters in obese, hypertriglyceridemic, insulin-resistant rhesus monkeys.Keywords
This publication has 32 references indexed in Scilit:
- Insulin Signaling and Insulin Sensitizing in Muscle and Liver of Obese Monkeys: Peroxisome Proliferator-Activated Receptor Gamma Agonist Improves Defective Activation of Atypical Protein Kinase CAntioxidants & Redox Signaling, 2011
- Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetesBioorganic & Medicinal Chemistry Letters, 2009
- A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart diseaseCardiovascular Diabetology, 2009
- Standards of Medical Care in Diabetes—2008Diabetes Care, 2008
- Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)European Journal of Preventive Cardiology, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Skeletal muscle glycogen synthase subcellular localization: effects of insulin and PPAR-α agonist (K-111) administration in rhesus monkeysAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeysJournal of Lipid Research, 2005
- The Effects of K-111, a New Insulin-sensitizer, on Metabolic Syndrome in Obese Prediabetic Rhesus MonkeysHormone and Metabolic Research, 2003
- Decreased Hepatic Insulin Extraction Precedes Overt Noninsulin Dependent (Type II) Diabetes in Obese MonkeysObesity Research, 1993